Market Overview

Pete Najarian Sees Unusual Options Activity In SPDR S&P Biotech

Related XBI
Heaps Of Healthy Health Care ETFs
What Pharmaceuticals Spend On Lobbying To Influence Trump

On CNBC's "Fast Money Halftime Report", Pete Najarian spoke about high options volume in SPDR S&P Biotech (ETF) (NYSE: XBI).

He said that around 22,000 contracts of the November 90 calls were bought for $2. It's unusual to see that much volume in SPDR S&P Biotech, explained Najarian. The trade breaks even at $92 or 4.26 percent above the current market price. Najarian decided to follow the trade.

Posted-In: Fast Money Halftime Report Pete NajarianCNBC Options Markets Media ETFs


Related Articles (XBI)

View Comments and Join the Discussion!

Partner Center